9 years ago

Evaluate Group Secures Equity Investment from HgCapital

  • Evaluate Group, a London-based provider of commercial intelligence for the global life sciences industry, received an equity investment from HgCapital

  • The terms of the transaction were not disclosed

  • The company intends to utilize the funds to further scale its operations

  • Evaluate Group specializes in providing mission-critical commercial information for complex business decisions in the pharmaceutical industry

  • Their core product is a set of analyst consensus forecasts that offer detailed insights at various levels

  • The company integrates data from multiple sources to provide tools that drive analytical insights from data.

      • ProblemTechnology

      "Pharmaceutical companies need reliable and accurate data to make informed decisions about their products, but finding and analyzing this data from various sources can be time-consuming and challenging."

      Solution

      "Evaluate provides a centralized platform that gathers and analyzes data from company filings, research organizations, and government bodies, giving pharmaceutical companies a comprehensive view of the market and allowing them to make informed decisions about their products."

      Covered on